See every side of every news story
Published loading...Updated

#Ultragenyx Pharmaceutical Fuels Strategic Growth and Talent Acquisition through Targeted Stock Grants amid Competitive Landscape,

Summary by csimarket.com
Ultragenyx Pharmaceutical Inc. Strengthens Workforce and Growth Potential Through Strategic Stock Grant Initiatives On March 19, 2025, Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company specializing in therapies for rare and ultrarare diseases, announced the granting of 21,806 restricted stock units (RSUs) to 16 newly hired non-executive officers. This initiative, approved by the company's compensation committee, falls un…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

csimarket.com broke the news in on Thursday, March 20, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.